agonist, implants in suppressing estrus behavior and matings in a controlled ambient
environment in feline queens in the presence of a tomcat. Local and utero-ovarian side
effects of deslorelin implants were also investigated. The queens were housed in groups
and assigned to one of three treatments: group 1 received 9.5 mg deslorelin implants (N=
14), group 2 received 5 mg megestrol acetate tablets and 9.5 mg deslorelin implants (N= 7) …